Related references
Note: Only part of the references are listed.Molecular Mechanisms and Treatment Options for Muscle Wasting Diseases
Markus A. Rueegg et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 51, 2011 (2011)
Establishment of clonal myogenic cell lines from severely affected dystrophic muscles-CDK4 maintains the myogenic population
Guido Stadler et al.
SKELETAL MUSCLE (2011)
TGF-β1 signal pathway may contribute to rhabdomyosarcoma development by inhibiting differentiation
Shouli Wang et al.
CANCER SCIENCE (2010)
Progressive skeletal muscle weakness in transgenic mice expressing CTG expansions is associated with the activation of the ubiquitin-proteasome pathway
Alban Vignaud et al.
NEUROMUSCULAR DISORDERS (2010)
Large CTG Repeats Trigger p16-Dependent Premature Senescence in Myotonic Dystrophy Type 1 Muscle Precursor Cells
Anne Bigot et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
CONGENITAL MUSCULAR DYSTROPHY Part I: a review of phenotypical and diagnostic aspects
Umbertina Conti Reed
ARQUIVOS DE NEURO-PSIQUIATRIA (2009)
Gene therapy for muscular dystrophy: current progress and future prospects
Capucine Trollet et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
Immortalized Skin Fibroblasts Expressing Conditional MyoD as a Renewable and Reliable Source of Converted Human Muscle Cells to Assess Therapeutic Strategies for Muscular Dystrophies: Validation of an Exon-Skipping Approach to Restore Dystrophin in Duchenne Muscular Dystrophy Cells
Soraya Chaouch et al.
HUMAN GENE THERAPY (2009)
In Vivo Myogenic Potential of Human CD133+ Muscle-derived Stem Cells: A Quantitative Study
Elisa Negroni et al.
MOLECULAR THERAPY (2009)
Replicative aging down-regulates the myogenic regulatory factors in human myoblasts
Anne Bigot et al.
BIOLOGY OF THE CELL (2008)
Facioscapulohumeral muscular dystrophy
Rabi Tawil
NEUROTHERAPEUTICS (2008)
Cellular senescence in human myoblasts is overcome by human telomerase reverse transcriptase and cyclin-dependent kinase 4: consequences in aging muscle and therapeutic strategies for muscular dystrophies
Chun-Hong Zhu et al.
AGING CELL (2007)
Premature proliferative arrest of cricopharyngeal myoblasts in oculo-pharyngeal muscular dystrophy:: Therapeutic perspectives of autologous myoblast transplantation
Sophie Perie et al.
NEUROMUSCULAR DISORDERS (2006)
Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatment - Third in Molecular Medicine Review Series
KJ Nowak et al.
EMBO REPORTS (2004)
Lentivector-mediated transfer of Bmi-1 and telomerase in muscle satellite cells yields a Duchenne myoblast cell line with long-term genotypic and phenotypic stability
C Cudré-Mauroux et al.
HUMAN GENE THERAPY (2003)
Extended amplification in vitro and replicative senescence:: Key factors implicated in the success of human myoblast transplantation
RN Cooper et al.
HUMAN GENE THERAPY (2003)
Defective membrane repair in dysferlin-deficient muscular dystrophy
D Bansal et al.
NATURE (2003)
Regenerative potential of human skeletal muscle during aging
V Renault et al.
AGING CELL (2002)
Historical claims and current interpretations of replicative aging
WE Wright et al.
NATURE BIOTECHNOLOGY (2002)
A new immunodeficient mouse model for human myoblast transplantation
RN Cooper et al.
HUMAN GENE THERAPY (2001)
Animal models for muscular dystrophy: valuable tools for the development of therapies
V Allamand et al.
HUMAN MOLECULAR GENETICS (2000)
Skeletal muscle regeneration and the mitotic clock
V Renault et al.
EXPERIMENTAL GERONTOLOGY (2000)
Share Paper
